Abstract
Studies in vitro have shown that a respiratorydeficient phenotype is expressed by cells when the proportion of mtDNA with a disease-associated mutation exceeds a threshold level, but analysis of tissues from patients with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS) have failed to show a consistent relationship between the degree of heteroplasmy and biochemical expression of the defect. One possible explanation for this phenomenon is that there is variation of heteroplasmy between individual cells that is not adequately reflected by the mean heteroplasmy for a tissue. We have confirmed this by study of fibroblast clones from subjects heteroplasmic for the MELAS 3243 (A→ G) mtDNA mutation. Similar observations were made with fibroblast clones derived from two subjects heteroplasmic for the 11778 (G→A) mtDNA mutation of Leber's hereditary optic neuropathy. For the MELAS 3243 mutation, the distribution of mutant mtDNA between different cells was not randomly distributed about the mean, suggesting that selection against cells with high proportions of mutant mtDNA had occurred. To explore the way in which heteroplasmic mtDNA segregates in mitosis we followed the distribution of heteroplasmy between clones over approximately 15 generations. There was either no change or a decrease in the variance of intercellular heteroplasmy for the MELAS 3243 mutation, which is most consistent with segregation of heteroplasmic units of multiple mtDNA molecules in mitosis. After mitochondria from one of the MELAS 3243 fibroblast cultures were transferred to a mitochondrial DNA-free (ρ0) cell line derived from osteosarcoma cells by cytoplast fusion, the mean level and intercellular distribution of heteroplasmy was unchanged. We interpret this as evidence that somatic segregation (rather than nuclear background or cell differentiation state) is the primary determinant of the level of heteroplasmy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boulet L, Karpati G, Shoubridge EA (1992) Distribution and threshold expression of the tRNALys mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 51:1187–1200
Brown MD, Voljavec AS, Lott MT, MacDonald I, Wallace DC (1992) Leber's hereditary optic neuropathy: a model for mitochondrial neurodegenerative diseases: a review. FASEB J 6:2791–2799
Chomyn A, Martinuzzi A, Yoneda M, Daga A, Hurko O, Johns D, Lai ST, Angelini C, Attardi G (1992) MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA 89:4221–4225
Chomyn A, Martinuzzi A, Yonada M, Daga A, Hurko O, Johns D, Lai ST, Nonaka I, Angelini C, Attardi G (1994) MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA 89:4221–4225
Ciafaloni E, Ricci E, Servidei S, Shanske S, Silvestri G, Manfredi G, DiMauro S (1991) Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology 41:1663–1664
Ciafaloni E, Ricci E, Shanske S, Moraes CT, Silvestri G, Hirano M, Angelini C, Donati MA, Garcia C, et al (1992) MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 31:391–398
DiMauro S (1993) Mitochondrial encephalomyopathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi R, Kunkel L (eds) The molecular and genetic basis of neurological disease. Butterworth-Heinemann, Boston, pp 665–694
Goto Y, Horai S, Matsuoka T, Koga Y, Nihei K, Kobayashi M, Nonaka I (1992) Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 42:545–550
Hammans SR, Sweeney MG, Holt JM, Cooper JM, Toscan A, Clark JB, Morgan-Hughes JA, et al (1992) Evidence for intramitochondrial complementation between deleted and normal mitochondrial DNA in some patients with mitochondrial myopathy. J Neurol Sci 107:87–92
Hirano M, Ricci E, Koenigsberger MR, Defendini R, Pavlakis SG, DeVivo DC, DiMauro S, Rowland LP (1992) MELAS: an original case and clinical criteria for diagnosis: a review. Neuromuscul Disord 2:125–135
King MP, Koga Y, Davidson M, Schon EA (1992) Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNALeu(UUR) mutation associated with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. Mol Cell Biol 12:480–490
Kobayashi Y, Ichihashi K, Ohta S, Nihei K, Kagawa Y, Yanagisawa M (1992) The mutant mitochondrial genes in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) were selectively amplified through generations. J Inherit Metab Dis 15:803–808
Larsson NG, Tulinius MH, Holme E, Oldfors A, Andersen O, Wahlstrom J, Aasly J (1992) Segregation and manifestations of the mtDNA tRNA(Lys) A→G(8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet 51:1201–1212
Matthews PM, Hopkin J, Brown R, Stephenson J, Hilton-Jones D, Brown GK (1994) Comparison of the relative levels of the 3243 (A→G) mtDNA mutation in heteroplasmic adult and fetal tissues. J Med Genet 31:41–44
Moorman CM, Elston JS, Matthews PM (1993) Leber's hereditary optic neuropathy as a cause of severe visual loss in childhood. Pediatrics 91:988–989
Newman NJ, Lott MT, Wallace DC (1991). The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 111:750–762
Obermeier-Kusser B, Paetke-Brunner I, Enter C, et al (1991) Respiratory chain activity in tissues from patients (MELAS) with a point mutation of the mitochondrial genome [tRNALeu(UUR)]. FEBS Lett 286:67–70
Oliver NA, Wallace DC (1982) Assignment of two mitochondrially synthesized polypeptides to human mitochondrial DNA and their use in the study of intracellular mitochondrial interaction. Mol Cell Biol 2:30–41
Poulton J, Morten K (1993) Noninvasive diagnosis of the MELAS syndrome from blood DNA (letter). Ann Neurol 34:116
Robin ED, Wong R (1988) Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian. J Cell Physiol 136:507–513
Shoffner JM, Wallace DC (1992) Mitochondrial genetics: principles and practice (editorial). Am J Hum Genet 51:1179–1186
Solignac M, Genermont J, Monnerot M, Mounolou JC (1984) Genetics of mitochondria in Drosophila: mtDNA inheritance in heteroplasmic strains of D. Mauritania. Mol Gen Genet 197:183–188
Stone EM, Coppinger JM, Kardon RH, Donelson J (1990) MaeII positively detects the mitochondrial mutation associated with type I Leber's hereditary optic neuropathy. Arch Opthalmol 108:1417–1420
Wallace DC (1992) Diseases of the mitochondrial DNA. Annu Rev Biochem 61:1175–1212
Wallace DC, Lott MT, Lezza AMS, Seibel P, Voljavec AS, Shoffner JM (1990) Mitochondrial DNA mutations associated with neuromuscular diseases: analysis and diagnosis using the olymerase chain reaction. Pediatr Res 28:525–528
Wharton DC, Tzagaloff A (1967) Cytochrome oxidase from beef heart mitochondria. Methods Enzymol 10:245–250
Yoneda M, Miyatake T, Attardi G (1994) Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles. Mol Cell Biol 14:2699–2712
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matthews, P.M., Brown, R.M., Morten, K. et al. Intracellular heteroplasmy for disease-associated point mutations in mtDNA: implications for disease expression and evidence for mitotic segregation of heteroplasmic units of mtDNA. Hum Genet 96, 261–268 (1995). https://doi.org/10.1007/BF00210404
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00210404